Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tugwell

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Rheumatology|September 10, 2009
Responsiveness of the Effective Consumer Scale (EC-17)Nancy Santesso, Tamara Rader, George A Wells, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
The Journal of Rheumatology|September 10, 2009
Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9John R Kirwan, Stanton Newman, Peter S Tugwell, et al.
The Journal of Rheumatology|September 3, 2015
OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology ResearchDorcas E Beaton, Sarah Dyer, Annelies Boonen, et al.
The Journal of Rheumatology|October 17, 2013
Worker productivity outcome measures: OMERACT filter evidence and agenda for future researchKenneth Tang, Annelies Boonen, Suzanne M M Verstappen, et al.
The Journal of Rheumatology|May 3, 2017
An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working GroupMonika E Finger, Annelies Boonen, Thasia G Woodworth, et al.
The Journal of Rheumatology|September 10, 2009
How to ascertain drug safety in the context of benefit. Controversies and concernsLee S Simon, C Vibeke Strand, Maarten Boers, et al.
The Journal of Rheumatology|September 3, 2015
Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT ProcessJoanna C Robson, Nataliya Milman, Gunnar Tomasson, et al.
The Journal of Rheumatology|June 17, 2015
Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome MeasuresJennifer Petkovic, Jonathan Epstein, Rachelle Buchbinder, et al.
The Journal of Rheumatology|April 17, 2015
Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision MakingKarine Toupin-April, Jennifer Barton, Liana Fraenkel, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Rheumatology|September 10, 2009
Responsiveness of the Effective Consumer Scale (EC-17)Nancy Santesso, Tamara Rader, George A Wells, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
The Journal of Rheumatology|September 10, 2009
Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9John R Kirwan, Stanton Newman, Peter S Tugwell, et al.
The Journal of Rheumatology|September 3, 2015
OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology ResearchDorcas E Beaton, Sarah Dyer, Annelies Boonen, et al.
The Journal of Rheumatology|October 17, 2013
Worker productivity outcome measures: OMERACT filter evidence and agenda for future researchKenneth Tang, Annelies Boonen, Suzanne M M Verstappen, et al.
The Journal of Rheumatology|May 3, 2017
An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working GroupMonika E Finger, Annelies Boonen, Thasia G Woodworth, et al.
The Journal of Rheumatology|September 10, 2009
How to ascertain drug safety in the context of benefit. Controversies and concernsLee S Simon, C Vibeke Strand, Maarten Boers, et al.
The Journal of Rheumatology|September 3, 2015
Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT ProcessJoanna C Robson, Nataliya Milman, Gunnar Tomasson, et al.
The Journal of Rheumatology|June 17, 2015
Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome MeasuresJennifer Petkovic, Jonathan Epstein, Rachelle Buchbinder, et al.
The Journal of Rheumatology|April 17, 2015
Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision MakingKarine Toupin-April, Jennifer Barton, Liana Fraenkel, et al.
Pageof 6